A Resolution designating the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania.
Summary
House Resolution 124 designates September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania. The resolution is primarily commemorative and educational: it recites background information about prostate cancer, including its prevalence, risk factors, symptoms, and the importance of screening and early detection. It also highlights that prostate cancer can be asymptomatic for long periods and notes recommended screening ages for men at average and elevated risk.
In addition to the state designation, the resolution urges Congress to support federal H.R. 1300, which would require certain health plans and insurance policies to cover preventive prostate cancer screenings without cost-sharing for men with a personal or family history of prostate cancer. The resolution further directs that copies be sent to congressional leaders and Pennsylvania’s congressional delegation.
Impact
HR124 does not amend Pennsylvania statutes or create new regulatory requirements. Its legal effect is limited to formally recognizing September 2025 as Prostate Cancer Awareness Month and expressing the House’s support for federal legislation related to prostate cancer screening coverage. The practical impact is symbolic and advocacy-oriented, aimed at raising public awareness and encouraging broader access to screening through federal action rather than changing state insurance law directly.
Sentiment
The overall sentiment around the resolution is strongly supportive and noncontroversial. The bill’s findings emphasize the seriousness of prostate cancer, the benefits of early detection, and the potential life-saving value of screening, suggesting a public health-oriented consensus. No committee debate, recorded votes, or opposition were provided in the bill context, and the sponsor list indicates broad bipartisan support.
Contention
No specific points of contention are identified in the available materials. The only policy issue implied by the resolution is the federal screening-coverage proposal referenced in H.R. 1300, which could raise questions about insurance mandates and cost-sharing, but the Pennsylvania resolution itself does not impose those requirements. Because there are no transcripts or votes, there is no documented disagreement among legislators or stakeholders in the provided record.